The Role of Autophagy in Cancer: Therapeutic Implications

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Oncology".

Deadline for manuscript submissions: closed (30 June 2021) | Viewed by 2466

Special Issue Editor


E-Mail Website
Guest Editor
Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 00133 Rome, Italy
Interests: cell death; apoptosis; autophagy; mitophagy; mitochondria; cancer; neurodegeneration

Special Issue Information

Dear Colleagues,

Consistent with a physiological adaptive strategy to stressful conditions, disruption of autophagy was found to contribute to the pathogenesis of cancer. The molecular exploration of the significance of this cellular process for cancer development and progression that possesses an ambiguous dual role in reply to adverse stress events has only recently been initiated. As a physiological adaption to the frequently encountered apoptosis resistance in early phases of tumorigenesis, autophagy seems to resume a suppressive role that confines tumor necrosis and inflammation by the removal of cell damaging factors (e.g. oncoproteins), or even mediates cell death in malignant cells. During later stages of tumor development, autophagy appears to be reprogrammed by the cancer cell to prevent its elimination and support tumor progression. Here, autophagy provides cell survival factors and withdraws metabolic stress products that are particularly activated by pharmacological interference during cancer treatment.  Increasing evidence also implicates an important role of autophagy in developing resistance to cancer therapeutics.

The underlying factors of the cell determining the protective or cytotoxic nature of the autophagic response are largely unclear, however. Nonetheless, it would be of crucial significance to affirm the context-dependent role of autophagy by previous investigation of the limiting molecular determinants for a positive therapeutic outcome. This special issue will therefore focus on new insights and address regulatory molecular mechanisms of autophagy that suppress or promote cancer development.

Dr. Carlo Rodolfo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Autophagy
  • Cancer
  • Dual role
  • Cell death
  • Molecular determinants
  • Tumor-suppressive
  • Tumor-promoting
  • Apoptosis resistance
  • Therapy resistance
  • Cancer therapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 485 KiB  
Article
The Expression Patterns of BECN1, LAMP2, and PINK1 Genes in Colorectal Cancer Are Potentially Regulated by Micrornas and CpG Islands: An In Silico Study
by Martyna Bednarczyk, Edyta Fatyga, Sylwia Dzięgielewska-Gęsiak, Dariusz Waniczek, Beniamin Grabarek, Nikola Zmarzły, Grażyna Janikowska and Małgorzata Muc-Wierzgoń
J. Clin. Med. 2020, 9(12), 4020; https://doi.org/10.3390/jcm9124020 - 12 Dec 2020
Cited by 6 | Viewed by 2079
Abstract
Background: Autophagy plays a dual role of tumor suppression and tumor promotion in colorectal cancer. The study aimed to find those microRNAs (miRNAs) important in BECN1, LAMP2, and PINK1 regulation and to determine the possible role of the epigenetic changes in [...] Read more.
Background: Autophagy plays a dual role of tumor suppression and tumor promotion in colorectal cancer. The study aimed to find those microRNAs (miRNAs) important in BECN1, LAMP2, and PINK1 regulation and to determine the possible role of the epigenetic changes in examined colorectal cancer using an in silico approach. Methods: A total of 44 pairs of surgically removed tumors at clinical stages I‒IV and healthy samples (marginal tissues) from patients’ guts were analyzed. Analysis of the obtained results was conducted using the PL-Grid Infrastructure and Statistica 12.0 program. The miRNAs and CpG islands were estimated using the microrna.org database and MethPrimer program. Results: The autophagy-related genes were shown to be able to be regulated by miRNAs (BECN1—49 mRNA, LAMP2—62 mRNA, PINK1—6 mRNA). It was observed that promotion regions containing at least one CpG region were present in the sequence of each gene. Conclusions: The in silico analysis performed allowed us to determine the possible role of epigenetic mechanisms of regulation gene expression, which may be an interesting therapeutic target in the treatment of colorectal cancer. Full article
(This article belongs to the Special Issue The Role of Autophagy in Cancer: Therapeutic Implications)
Show Figures

Figure 1

Back to TopTop